
Jubilant FoodWorks (JFL) has said it will not renew its franchise agreement with US-based coffee-and-doughnut chain Dunkin’ in India once the current arrangement ends on 31 December 2026.
The two businesses signed a multiple-unit development franchise agreement (MUDFA) in February 2011, which granted JFL the rights to develop and run Dunkin’ outlets in the country.
In a filing, JFL stated it will “in an orderly and phased manner, evaluate and undertake such actions as may be considered appropriate in respect of its existing Dunkin’ brand operations, including rationalisation and/or cessation of certain operations and/or sale, transfer or disposal of assets and/or assignment or transfer of franchise rights, as may be required, in consultation with owners of Dunkin’ brand”.
JFL added that the move is not expected to have any material operational or financial impact.
Dunkin’s expansion in India has remained limited while JFL has increasingly concentrated on its Domino’s pizza business and newer formats such as the fried chicken chain Popeyes.
The Dunkin’ brand contributed 0.61% of the company’s revenue in the 2025 financial year and posted a loss of around Rs191m during the period.
Jubilant operated 27 Dunkin’ stores in India as of December 2025 and closed seven outlets over the previous year, according to its third-quarter investor presentation.
For the October–December quarter, the company reported profit of Rs709m ($7.49m), an increase of 65% from Rs429.1m a year earlier.
Earlier this week, JFL revealed that some outlets are facing restricted access to commercial liquefied petroleum gas (LPG) cylinders amid the ongoing conflict in West Asia.
The company added that it is working to conserve LPG and planning a transition to alternate energy sources such as electricity and piped natural gas (PNG).
"Jubilant FoodWorks to scrap Dunkin’ franchise arrangement in India" was originally created and published by Verdict Food Service, a GlobalData owned brand.
The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
LATEST POSTS
- 1
New York to require social media platforms to display mental health warnings - 2
'Seditious behavior': Trump accuses Democrats who made video reminding the military not to follow illegal orders of a crime — but is it? - 3
A Russian fighting for Ukraine conned the Kremlin out of $500,000 by faking his own death - 4
Scientists captured female sperm whales on video working together during a birth to protect the calf - 5
2 bright planets light up April evenings — here's where and when to look
Agios Pharma shares jump as US FDA expands approval for its blood disorder drug
The 10 Most Persuasive Forerunners in Innovation
Washington resident contracts bird flu, first human case in U.S. since February
Vote in favor of your #1 Sort of Convenience for a Family
Choosing the Ideal Bed for Quality Rest and Solace
Guns N' Roses 2026 Tour: How to get tickets, presale times, prices and more
‘The White Lotus’ sparked online interest in risky anxiety pills, study says
Tech Development Disclosed: A Survey of \Usefulness and Configuration in Concentration\ Tech Item
Manual for Vegetarian Protein Powder













